ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,357,000 | +5.2% | 58,139 | -25.1% | 0.00% | 0.0% |
| Q3 2021 | $1,290,000 | -95.8% | 77,640 | -86.6% | 0.00% | -95.5% |
| Q4 2020 | $31,037,000 | +393.6% | 580,567 | +280.9% | 0.02% | +340.0% |
| Q3 2020 | $6,288,000 | -14.6% | 152,431 | +0.4% | 0.01% | -28.6% |
| Q2 2020 | $7,359,000 | +4.2% | 151,823 | -9.2% | 0.01% | -22.2% |
| Q1 2020 | $7,065,000 | +10.4% | 167,227 | +11.8% | 0.01% | +50.0% |
| Q4 2019 | $6,399,000 | -83.8% | 149,585 | -89.1% | 0.01% | -86.4% |
| Q4 2016 | $39,588,000 | +2324.2% | 1,372,679 | +2249.8% | 0.04% | +2100.0% |
| Q1 2016 | $1,633,000 | -92.3% | 58,417 | -90.2% | 0.00% | -90.5% |
| Q4 2015 | $21,148,000 | -41.7% | 593,206 | -45.9% | 0.02% | -43.2% |
| Q3 2015 | $36,290,000 | -65.6% | 1,097,364 | -56.5% | 0.04% | -61.9% |
| Q2 2015 | $105,593,000 | +30.6% | 2,521,324 | +1.6% | 0.10% | +31.1% |
| Q1 2015 | $80,863,000 | -11.4% | 2,481,221 | -13.7% | 0.07% | -12.9% |
| Q4 2014 | $91,250,000 | +26.9% | 2,874,016 | -1.0% | 0.08% | +26.9% |
| Q3 2014 | $71,890,000 | +4.2% | 2,903,489 | -4.9% | 0.07% | +6.3% |
| Q2 2014 | $68,979,000 | -7.0% | 3,053,525 | +0.1% | 0.06% | -11.3% |
| Q1 2014 | $74,192,000 | +89.9% | 3,049,417 | +95.0% | 0.07% | +86.8% |
| Q4 2013 | $39,073,000 | -6.0% | 1,563,551 | +3.3% | 0.04% | -13.6% |
| Q3 2013 | $41,567,000 | +50.4% | 1,513,192 | -0.6% | 0.04% | +41.9% |
| Q2 2013 | $27,643,000 | – | 1,523,014 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |